Drekab,

The technology needs to be tested by a third party for time and sensitivity and then recognized as competitive, better, or the technology of choice before it can be used for clinical testing.

That's been announced by NanoLogix as the next step, where a multi-institution study is in the works.

Then the results are published and presented.

Then it should be in use for diagnostics for humans.

Scott